Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1143239

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent preparations his Department has made to ensure the supply of medicines will be maintained from the EU to the UK in the event that the UK leaves the EU without a withdrawal agreement.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	284724
answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines to the whole of the United Kingdom and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p> </p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 18:48:47 answering member 4021 label Biography information for Chris Skidmore
tabling member	4621 label Biography information for Darren Jones

1136736

registered interest
date	03/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Facial Palsy: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will review the way that facial palsy treatment is (a) assessed and (b) funded.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	272915
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>It is for the local clinical commissioning groups to commission high-quality services that meet the needs of their local population. Decisions about treatment, including for palsy, should always be based on patients’ clinical needs and informed by the National Institute for Health and Care Excellence’s (NICE) guidelines.</p><p> </p><p>NICE clinical guidelines make many recommendations spanning all stages of care from diagnosis to treatment of a condition. Health professionals and organisations are expected to take the guidance fully into account when deciding what treatments to give people.</p><p> </p><p>The NICE guidelines on the management of Bell’s Palsy can be found at the following link:</p><p><a href="https://cks.nice.org.uk/bells-palsy#!scenario" target="_blank">https://cks.nice.org.uk/bells-palsy#!scenario</a></p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/07/2019 13:35:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	4621 label Biography information for Darren Jones

1129191

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	259400
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.</p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:51:00 question first ministerially corrected 12/06/2019 14:34:05 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ259400 table formatted.docx title Prescription data benzodiazipines & antidepressant previous answer version 122124 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4621 label Biography information for Darren Jones

1092072

registered interest
date	20/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to prioritise patients with (a) terminal cancer and (b) cancer for the receipt of drugs in the event of medicine shortages due to the UK leaving the EU (i) without an agreement and (ii) with an agreement under which the medicine supply is restricted.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	234769
answer	answer is ministerial correction date of answer 25/03/2019 answer text <p>Leaving the European Union with a deal remains the Government’s top priority. However, as a responsible Government we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>The Government has been working closely with industry to ensure the supply of medicines, including those for cancer patients, can continue uninterrupted in the event of a ‘no deal’ EU exit, including building stockpiles, providing additional warehousing space and buying freight capacity on alternative ferry routes.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the United Kingdom that come from, or via, the EU/European Economic Area asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in the event of a ‘no deal’ EU exit.</p><p> </p><p>The Department has put in place a multi-layered approach to minimise any supply disruption, which includes securing, via the Department for Transport, additional roll on roll off freight capacity away from the short straits crossings to Dover and Folkestone for goods to continue to come into the UK from 29 March. In addition to asking industry to build up stockpiles in the UK ahead of 29 March we have bought extra warehouse space for the additional stock to be held in. We are supporting companies in booking space on aircraft for products which require an immediate shipment due to short shelf-life or specific storage conditions. We have also made changes to, or clarifications of, certain regulatory requirements so that companies can continue to sell their products in the UK even if we have no deal. Finally, we are strengthening the processes and resources used to deal with shortages in the event that they do occur.</p><p> </p><p>We are confident that, if everyone does what they need to do, the supply of medicines and medical products will be uninterrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 25/03/2019 16:06:45 answering member 1585 label Biography information for Stephen Hammond
tabling member	4621 label Biography information for Darren Jones

1091069

registered interest
date	18/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Terminal Illnesses: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government has in place to ensure that people accessing secondary health care for terminal illnesses who are (a) reliant on life-extending and (b) dependent on drugs do not have their drugs supply interrupted in the event that the UK leaves the EU (i) without an agreement and (ii) with an agreement under which the medicine supply is restricted.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	233642
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>Leaving the European Union with a deal remains the Government’s top priority. However, as a responsible Government we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p>The Government has been working closely with industry to ensure the supply of medicines, including those which are used to treat people with terminal illnesses, can continue uninterrupted in the event of a ‘no deal’ EU exit, including building stockpiles, providing additional warehousing space and buying freight capacity on alternative ferry routes.</p><p>The Department, together with industry and the National Health Service, has analysed the supply chains of 12,300 medicines and we are grateful for excellent engagement from all parties, which means our plans are well advanced.</p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines, including those used to treat patients with terminal illnesses, to the United Kingdom that come from or via the EU/European Economic Area, asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in the event of a ‘no deal’ EU exit.</p><p>The Department has put in place a multi-layered approach to minimise any supply disruption. We are confident that, if everyone does what they need to do, the supply of medicines and medical products will be uninterrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 21/03/2019 17:41:19 answering member 1585 label Biography information for Stephen Hammond
tabling member	4621 label Biography information for Darren Jones

1091070

registered interest
date	18/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Babylon Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he holds information on the amount of revenue allocated from the NHS GP funding formula which Babylon Healthcare has spent on primary healthcare in each of the last five years; and if he will make a statement.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	233643
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/03/2019 16:11:46 answering member 4067 label Biography information for Steve Brine
tabling member	4621 label Biography information for Darren Jones